Sign in
Home
About Us
Contact Us
Privacy Policy
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Australian Biotech Company News
Home
About Us
Contact Us
Privacy Policy
Home
Tags
Rare disease
Tag: Rare disease
Biotechnology
Update: Novartis’ Gene Therapy Zolgensma Gets Nod from EU
BioChannel
-
May 19, 2020
Biotechnology
Phase III Failure Sinks Drug for Rare Neurological Disorder
BioChannel
-
May 8, 2020
Biotechnology
Update: FDA Imposes No Penalties for Novartis Data Manipulation Scandal
BioChannel
-
April 2, 2020
Biotechnology
Ipsen Resumes Phase III Testing for Rare Disease Drug and Abandons...
BioChannel
-
March 31, 2020
Biotechnology
First-in-Class Drug For Inherited Metabolic Diseases Funded with €25M
BioChannel
-
February 10, 2020
Biotechnology
Rare Inflammatory Disease Drug Beats Immunosuppressants in Phase III
BioChannel
-
November 26, 2019
Biotechnology
€51M Nasdaq IPO Will Fund Centogene’s Rare Disease Diagnostics
BioChannel
-
November 7, 2019
Biotechnology
FDA Considers Imposing Penalties on Novartis over Data Manipulation
BioChannel
-
August 7, 2019
Biotechnology
This Biotech Treats a Neurological Autoimmune Disorder Using DNA
BioChannel
-
May 31, 2019
Biotechnology
Update: Novartis’ Neurological Gene Therapy Receives FDA Approval
BioChannel
-
May 24, 2019
1
2
Page 1 of 2
Stay connected
49,060
Followers
Follow
14,700
Subscribers
Subscribe
Recent posts
Life in the Time of Coronavirus
BioChannel
-
July 10, 2020
Study pinpoints brain cells that trigger sugar cravings and consumption
BioChannel
-
July 10, 2020
Life Sciences Fund Launches with €76M to Invest in Nordic Biotech
BioChannel
-
July 10, 2020
Random article
Life in the Time of Coronavirus
Study pinpoints brain cells that trigger sugar cravings and consumption
Life Sciences Fund Launches with €76M to Invest in Nordic Biotech
VarmX bags €32m in Series B round – European Biotechnology News
Edit with Live CSS